Everton N Alencar
Overview
Explore the profile of Everton N Alencar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santos S, Alencar E, Urtiga S, Oliveira W, Miranda J, Amaral-Machado L, et al.
AAPS PharmSciTech
. 2025 Mar;
26(3):84.
PMID: 40074961
Amphotericin B (AmB), a potent amphiphilic drug with antifungal and antileishmanial properties, exhibits reduced nephrotoxicity when delivered via lipid-based systems like microemulsions (ME). However, the complexity of these multi-phasic systems...
2.
Rodrigues V, Oliveira W, Pereira D, Alencar E, Porto D, Aragao C, et al.
Pharmaceutics
. 2023 Jan;
15(1).
PMID: 36678788
Copaiba oil has been largely used due to its therapeutic properties. Nanocapsules were revealed to be a great nanosystem to carry natural oils due to their ability to improve the...
3.
Sawangchan P, Alexandrino Junior F, Alencar E, Egito E, Kirsch L
Int J Pharm
. 2023 Jan;
632:122586.
PMID: 36623739
Amphotericin B (AmB) is a potent antimicrobial agent used in clinical practice. Nevertheless, the mechanism of its aqueous instability remains not yet fully understood, especially the role that its aggregation...
4.
Sette-de-Souza P, Costa M, Araujo F, Alencar E, Amaral-Machado L
An Acad Bras Cienc
. 2021 Nov;
93(suppl 4):e20210964.
PMID: 34817041
Influenza A virus, the main flu agent, affects billions of people worldwide. Conventional treatments still present limitations related to drug-resistance and severe side effects. As a result, natural product-derived molecules...
5.
Amaral-Machado L, Oliveira W, Torres-Rego M, Furtado A, Alencar E, Fernandes-Pedrosa M, et al.
Int J Nanomedicine
. 2021 Nov;
16:7353-7367.
PMID: 34754189
Background: Although bullfrog oil (BFO) exerts anti-inflammatory effects, it has undesirable properties limiting its use. Methodology: BFO nanocapsules (BFONc) were produced through nanoprecipitation, and their physicochemical and morphological properties were...
6.
Souza A, Ribeiro R, Pinheiro G, Pinheiro F, Oliveira W, Souza L, et al.
Pharmaceutics
. 2021 Jun;
13(6).
PMID: 34073997
Onychomycosis induced by spp. has several limitations regarding its treatment. Nail lacquers display the potential to overcome these drawbacks by providing therapeutic compliance and increasing local drug bioavailability. Thus, this...
7.
Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?
Dourado D, Freire D, Pereira D, Amaral-Machado L, Alencar E, de Barros A, et al.
Biomed Pharmacother
. 2021 Apr;
139:111578.
PMID: 33848774
The COVID-19 has become of striking interest since the number of deaths is constantly rising all over the globe, and the search for an efficient treatment is more urgent. In...
8.
Amaral-Machado L, Oliveira W, Rodrigues V, Albuquerque N, Alencar E, Egito E
Biomed Pharmacother
. 2020 Dec;
134:111143.
PMID: 33360048
Background: The ARDS (Acute Respiratory Distress Syndrome) is a severe respiratory syndrome that was recently associated as the main death cause in the COVID-19 pandemic outbreak. Hence, in order to...
9.
Alencar E, Sawangchan P, Kirsch L, Egito E
J Pharm Sci
. 2020 Nov;
110(3):1248-1258.
PMID: 33181186
The purpose of this work was to determine the degradation pathway of Amphotericin B (AmB) and its kinetics in lipid-based solutions. Mixtures of AmB in lipophilic solvent media were stored...
10.
Amaral-Machado L, Oliveira W, Moreira-Oliveira S, Pereira D, Alencar E, Tsapis N, et al.
Evid Based Complement Alternat Med
. 2020 Feb;
2020:1021258.
PMID: 32104188
Asthma, a disease classified as a chronic inflammatory disorder induced by airway inflammation, is triggered by a genetic predisposition or antigen sensitization. Drugs currently used as therapies present disadvantages such...